Samuel Bates Martin, SVP and CFO at Celldex Therapeutics, Inc. (CLDX), sold 2,738 shares at $45.25 ($124K) on 2021-08-10, disclosed to the SEC on 2021-08-12.
Open-market sale of $124k CLDX by SVP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.25 | 682 | $31K | 24.9% |
| 2 | $45.25 | 2,056 | $93K | 75.1% |
| Total | $45.25 avg | 2,738 | $124K | 100% |
| Filing → |
| CLDX | SELL | 2022-08-15 | $1.4M | — | Filing → |
| CLDX | SELL | 2021-12-28 | $399K | — | Filing → |
| CLDX | SELL | 2021-11-17 | $828K | — | Filing → |